Gilead Sciences Inc/ US3755581036 /
31/05/2024 22:15:00 | Var. +0.1900 | Volume | Denaro01:59:44 | Lettera01:59:44 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
64.2700USD | +0.30% | 14.51 mill. Fatturato: 649.39 mill. |
64.0000Quantità in denaro: 500 | 64.2500Quantità in lettera: 700 | 80.07 bill.USD | 4.67% | 14.16 |
GlobeNewswire
08:30
Orion is developing the Finnish life science industry in a unique collaboration project
GlobeNewswire
08:01
Flash News: OKX Announces Adjustments to Minimum Order Quantities for Select Futures Listings
GlobeNewswire
08:00
FTI Consulting Adds Senior Chemicals Industry Expert to Further Expand Business Transformation Pract...
GlobeNewswire
08:00
Caledonia to file preliminary economic assessment on chosen approach to develop the Bilboes sulphide...
GlobeNewswire
08:00
QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improv...
GlobeNewswire
07:48
Flash News: OKX Announces Enhancements to Portfolio Margin Mode to Optimize Trading Experience
GlobeNewswire
07:30
Vallourec: Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities)
GlobeNewswire
07:30
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead C...